Drug firm Suven Life Sciences today reported 56 per cent rise in standalone net profit to Rs 62.51 crore for the March quarter.
It had posted a net profit of Rs 40.06 crore for the corresponding period of the previous fiscal, Suven Life Sciences said in a filing to BSE.
Its standalone revenue from operations rose to Rs 213.72 crore for the fourth quarter of 2017-18. The revenue was Rs 180.14 crore in Q4 of 2016-17.
For the entire fiscal ended March this year, the company posted a net profit of Rs 158.42 crore as against Rs 123.47 crore in the previous fiscal.
Suven's standalone total revenue from operations rose to Rs 625.25 crore for 2017-18. It was Rs 544.47 crore in 2016-17.
The company's stock was up 4.65 per cent at Rs 190.30 on BSE.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)